首页 | 本学科首页   官方微博 | 高级检索  
     

舒洛地特治疗非糖尿病性慢性肾脏病的疗效观察
引用本文:秦建华,吴蔚桦,张帆,彭波. 舒洛地特治疗非糖尿病性慢性肾脏病的疗效观察[J]. 临床肾脏病杂志, 2012, 12(7): 320-322
作者姓名:秦建华  吴蔚桦  张帆  彭波
作者单位:四川省泸州医学院附属医院肾内科,64600泸州
摘    要:目的观察舒洛地特治疗非糖尿病性慢性肾脏病(CKD)2~3期的临床疗效及安全性。方法将40例非糖尿病性CKD2~3期患者随机分为对照组和治疗组,每组20例。对照组进行常规治疗(包括降压、肠道排毒及纠正贫血等处理);治疗组在对照组治疗的基础上加服舒洛地特胶囊25mg/次,2次/d,共50d。比较2组治疗后血肌酐、24h尿蛋白定量及纤维蛋白原含量。结果治疗组血肌酐、24h尿蛋白定量及纤维蛋白原含量明显低于对照组(P〈0.05)。结论舒洛地特治疗非糖尿病性CKD2~3期效果好,具有临床应用价值。

关 键 词:肾衰竭  慢性  舒洛地特  治疗效果

Effects of Sulodexide in the treatment of patients with chronic kidney disease
Affiliation:QIN Jian-hua, WU Wei- hua , ZHANG fan, et al. Department of Nephrology , the Affiliated Hospital of Luzhou Medical College,Luzhou 646000, China
Abstract:Objective To observe the effects of Sulodexide in the treatment of chronic kidney disease (CKD). Methods Forty patients with CKD were randomly divided into control group(routine treatment) and Sulodexide-treated group(routine treatment + Sulodexide). Results The serum creatinine, 24-4 urine protein secretion and fibrinogen in Sulodexide-treated group were significantly decreased as compared with those in control group(P〈0. 05). Conclusions Sulodexide is effective in the treatment of CKD.
Keywords:Kidney disease, Chronic  Sulodexide  Treatment outcome
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号